Venetoclax Plus Gilteritinib for FLT3 -Mutated Relapsed/Refractory Acute Myeloid Leukemia von Daver, Naval, Perl, Alexander E, Maly, Joseph, Levis, Mark, Ritchie, Ellen, Litzow, Mark, McCloskey, James, Smith, Catherine C, Schiller, Gary, Bradley, Terrence, Tiu, Ramon V, Naqvi, Kiran, Dail, Monique, Brackman, Deanna, Siddani, Satya, Wang, Jing, Chyla, Brenda, Lee, Paul, Altman, Jessica K

Volltext

Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable von Landsburg, Daniel J., Falkiewicz, Marissa K., Petrich, Adam M., Chu, Benjamin A., Behdad, Amir, Li, Shaoying, Medeiros, L. Jeffrey, Cassaday, Ryan D., Reddy, Nishitha M., Bast, Martin A., Vose, Julie M., Kruczek, Kimberly R., Smith, Scott E., Patel, Priyank, Hernandez‐Ilizaliturri, Francisco, Karmali, Reem, Rajguru, Saurabh, Yang, David T., Maly, Joseph J., Blum, Kristie A., Zhao, Weiqiang, Vanslambrouck, Charles, Nabhan, Chadi

Volltext

Contribution of male sex, age, and obesity to mechanical instability of the upper airway during sleep von Kirkness, Jason P, Schwartz, Alan R, Schneider, Hartmut, Punjabi, Naresh M, Maly, Joseph J, Laffan, Alison M, McGinley, Brian M, Magnuson, Thomas, Schweitzer, Michael, Smith, Philip L, Patil, Susheel P

Volltext

Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy von Greenwell, I. Brian, Staton, Ashley D., Lee, Michael J., Switchenko, Jeffrey M., Saxe, Debra F., Maly, Joseph J., Blum, Kristie A., Grover, Natalie S., Mathews, Stephanie P., Gordon, Max J., Danilov, Alexey V., Epperla, Narendranath, Fenske, Timothy S., Hamadani, Mehdi, Park, Steven I., Flowers, Christopher R., Cohen, Jonathon B.

Volltext

A Phase I/II Trial of Panobinostat in Combination with Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma von Maly, Joseph J., MD, Christian, Beth A., MD, Zhu, Xiaohua, PhD, Wei, Lai, PhD, Sexton, Jennifer L., MS, Jaglowski, Samantha M., MD, Devine, Steven M., BS MD, Fehniger, Todd A., PhD MD, Wagner-Johnston, Nina D., MD, Phelps, Mitch A., PhD, Bartlett, Nancy L., MD, Blum, Kristie A., MD

Volltext

Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival von Maly, Joseph J., Macrae, Erin R.

Volltext

Pembrolizumab in classical Hodgkin's lymphoma von Maly, Joseph, Alinari, Lapo

Volltext

S197: LINKER‐MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA von Lee, Hans C., Bumma, Naresh, Richter, Joshua, Dhodapkar, Madhav, Hoffman, James E., Suvannasankha, Attaya, Zonder, Jeffrey, Shah, Mansi R., Lentzsch, Suzanne, Maly, Joseph J., Ye, Jing Christine, Wu, Ka Lung, Deveaux, Michelle, Chokshi, Dhruti, Boyapati, Anita, Hazra, Anasuya, Lorenc, Karen Rodriguez, Kroog, Glenn, Houvras, Yariv, Jagannath, Sundar

Volltext

P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES von Robert Savona, Michael, K Mccloskey, James, A. Griffiths, Elizabeth, Yee, Karen, M. Zeidan, Amer, Al‐Kali, Aref, Joachim Deeg, H., A. Patel, Prapti, Sabloff, Mitchell, Keating, Mary‐Margaret, Y Zhu, Nancy, Gabrail, Nashat, Fazal, Salman, J. Maly, Joseph, Odenike, Olatoyosi, Kantarjian, Hagop, Dezern, Amy, L Oconnell, Casey, Roboz, Gail, Busque, Lambert, Buckstein, Rena, Amin, Harshad, K Randhawa, Jasleen, Leber, Brian, Dao, Kim‐Hien, Chan, Winny, Oganesian, Aram, Sano, Yuri, Mirakhur, Beloo, Keer, Harold, Garcia‐Manero, Guillermo

Volltext

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial von Smith, Matthew R, Scher, Howard I, Sandhu, Shahneen, Efstathiou, Eleni, Lara, Primo N, Yu, Evan Y, Chi, Kim N, Ståhl, Olof, Olmos, David, Danila, Daniel C, Espina, Byron M, Zhao, Xin, Urtishak, Karen A, Francis, Peter, Lopez-Gitlitz, Angela, Parnis, Francis, Horvath, Lisa G., Steer, Christopher, Marx, Gavin, Sandhu, Shahneen, Ferguson, Thomas, Luyten, Daisy, Lumen, Nicolaas, Dirix, Luc, Goeminne, Jean-Charles, Gil, Thierry, Vulsteke, Christof, Kussumoto, Celio, Franke, Fabio A., Martinelli de Oliveira, Fabricio Augusto, Pereira de Santana Gomes, Andrea Juliana, Preto, Daniel D'Almeida, Zucca, Luis Eduardo, Borges, Giuliano Santos, Murad, Andre M., Saad, Fred, Chi, Kim N., Fradet, Yves, Fleshner, Neil E., Emmenegger, Urban, Brasso, Klaus, Culine, Stephane, Thiery-Vuillemin, Antoine, Joly, Florence, Fléchon, Aude, Hilgers, Werner, Borchiellini, Delphine, Barthélémy, Philippe, Berger, Raanan, Mermershtain, Wilmosh, Peer, Avivit, Sella, Avishay, Voortman, Johannes, Aarts, Maureen J., Gietema, Jourik A., Choi, Young-Deuk, Gafanov, Rustem A., Kopyltsov, Evgeniy, Carles, Joan, Mellado, Begoña, Maroto, José Pablo, García-Donás, Jesús, Rodríguez Moreno, Juan Francisco, Durán, Ignacio, Pérez-Valderrama, Begoña, Castro, Elena, Olmos, David, Méndez-Vidal, María José, Muñoz-Langa, José, Herranz, Urbano Anido, Puente Vázquez, Javier, Castellanos, Enrique, Hellström, Martin, Widmark, Anders, Lissbrant, Ingela Franck, Jellvert, Åsa, Külich, Cecilia, Blom, René, Kang, Chih-Hsiung, Ou, Yen-Chuan, Wang, Shian-Shiang, Attard, Gerhardt, Bahl, Amit, Kellati, Prasad, Parikh, Omi, Srinivasan, Rajaguru, Lester, Jason F., Staffurth, John N., Cheng, Heather H., Efstathiou, Eleni, Pilié, Patrick G., George, Daniel J., Karsh, Lawrence I., Kelly, W. Kevin, Danila, Daniel C., Smith, Matthew R., Heath, Elisabeth I., Vaishampayan, Ulka N., Emamekhoo, Hamid, Pinski, Jacek K.

Volltext

AB-101, an allogeneic, non–genetically modified, natural killer (NK) cell therapy, evaluated as monotherapy or in combination with rituximab in R/R non-Hodgkin lymphoma von Khanal, Rashmi, Mehta, Amitkumar, Maly, Joseph J., Holmes, Houston, Saultz, Jennifer N., Hamdan, Ayad, Robinson, Anne M., Mandal, Mili, Patel, Aakash, Graef, Thorsten, Seto, Anita G., Farooq, Umar

Volltext

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission von Landsburg, Daniel J, Falkiewicz, Marissa K, Maly, Joseph, Blum, Kristie A, Howlett, Christina, Feldman, Tatyana, Mato, Anthony R, Hill, Brian T, Li, Shaoying, Medeiros, L Jeffrey, Torka, Pallawi, Hernandez-Ilizaliturri, Francisco, Reddy, Nishitha M, Singavi, Arun, Fenske, Timothy S, Chavez, Julio C, Kaplan, Jason B, Behdad, Amir, Petrich, Adam M, Bast, Martin A, Vose, Julie M, Olszewski, Adam J, Costa, Cristiana, Lansigan, Frederick, Gerson, James N, Barta, Stefan K, Calzada, Oscar, Cohen, Jonathon B, Lue, Jennifer K, Amengual, Jennifer E, Rivera, Xavier, Persky, Daniel O, Peace, David J, Nathan, Sunita, Cassaday, Ryan D

Volltext

Trial in Progress: AB-101, an Allogeneic, Non-Engineered, Cord Blood-Derived Natural Killer (NK) Cell Therapy, As Monotherapy or in Combination with Rituximab in Patients with Rela... von Khanal, Rashmi, Saultz, Jennifer N., Farooq, Umar, Nathan, Sunita, Mehta, Amitkumar, Hamdan, Ayad, Morris, Lawrence E., Holmes, Houston, Pinter-Brown, Lauren C., Lim, John K.C., Conerty, Amanda, Raymon, Heather, Flynn, Peter, Seto, Anita G., Maly, Joseph J.

Volltext

LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma von Lee, Hans C., Bumma, Naresh, Richter, Joshua Ryan, Dhodapkar, Madhav V., Hoffman, James E., Suvannasankha, Attaya, Zonder, Jeffrey A., Shah, Mansi R., Lentzsch, Suzanne, Maly, Joseph J., Ye, Jing Christine, Lung Wu, Ka, DeVeaux, Michelle, Chokshi, Dhruti, Boyapati, Anita, Hazra, Anasuya, Rodriguez-Lorenc, Karen, Kroog, Glenn Scott, Houvras, Yariv J., Jagannath, Sundar

Volltext

Patterns of Response to 200 Mg Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-Up of the Linker-MM1 Study von Jagannath, Sundar, Richter, Joshua, Dhodapkar, Madhav V., Hoffman, James E., Lee, Hans C., Suvannasankha, Attaya, Shah, Mansi R., Lentzsch, Suzanne, Zonder, Jeffrey A., Baz, Rachid, Maly, Joseph J., Namburi, Swathi, Wu, Ka Lung, Pianko, Matthew, Ye, Jing Christine, Silbermann, Rebecca, Min, Chang-Ki, Vekemans, Marie-Christiane, Munder, Markus, Byun, Ja Min, Lopez, Joaquín Martínez, DeVeaux, Michelle, Chokshi, Dhruti, Boyapati, Anita, Hazra, Anasuya, Rodriguez Lorenc, Karen, Kroog, Glenn S., Houvras, Yariv, Bumma, Naresh

Volltext

Health-Related Quality of Life (HRQoL) Among Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1: Interim Assess... von Hoffman, James E., Bumma, Naresh, Richter, Joshua, Dhodapkar, Madhav V., Lee, Hans C., Suvannasankha, Attaya, Houde, Christiane A., Maly, Joseph J., Shah, Mansi R., Baz, Rachid, Namburi, Swathi, Wu, Ka Lung, Pianko, Matthew, Ye, Jing Christine, Lentzsch, Suzanne, Silbermann, Rebecca, Min, Chang-Ki, Vekemans, Marie-Christiane, Munder, Markus, Byun, Ja Min, Lopez, Joaquín Martínez, DeVeaux, Michelle, Ivanescu, Cristina, Rodriguez Lorenc, Karen, Kroog, Glenn S., Houvras, Yariv, Inocencio, Timothy J., Chi, Lei, Harnett, James, Ma, Qiufei, Jagannath, Sundar

Volltext

Reclassification of Ascertain (ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) Ba... von Garcia-Manero, Guillermo, McCloskey, James, Griffiths, Elizabeth A., Zeidan, Amer M., Yee, Karen W.L., Al-Kali, Aref, Deeg, H. Joachim, Patel, Prapti A., Sabloff, Mitchell, Keating, Mary-Margaret, Zhu, Nancy, Gabrail, Nashat Y., Fazal, Salman, Maly, Joseph J., Odenike, Olatoyosi, Kantarjian, Hagop M., DeZern, Amy E., O'Connell, Casey L., Roboz, Gail J., Busque, Lambert, Buckstein, Rena, Amin, Harsh, Randhawa, Jasleen K., Leber, Brian, Lee, Shannon, Chan, Winny, Souza, Sonia, Sano, Yuri, Keer, Harold N., Savona, Michael R.

Volltext

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study von Bumma, Naresh, Richter, Joshua, Brayer, Jason, Zonder, Jeffrey A., Dhodapkar, Madhav, Shah, Mansi R., Hoffman, James E., Mawad, Raya, Maly, Joseph J., Lentzsch, Suzanne, Suvannasankha, Attaya, Roy, Pourab, Dey, Jyotirmoy, Chokshi, Dhruti, Boyapati, Anita, Visich, Jenn, Houvras, Yariv, Rodriguez Lorenc, Karen, Kroog, Glenn S., Jagannath, Sundar

Volltext

Venetoclax in Combination with Gilteritinib in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1b Study von Perl, Alexander E., Daver, Naval G., Pratz, Keith W., Maly, Joseph, Hong, Wan-Jen, Bahceci, Erkut, Tong, Bo, Tian, Tian, Dilley, Kimberley

Volltext

Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia in the Expansion Cohort of a Phase 1b Study von Daver, Naval, Altman, Jessica K., Maly, Joseph, Levis, Mark, Ritchie, Ellen, Litzow, Mark, McCloskey, James K., Smith, Catherine C., Schiller, Gary J., Bradley, Terrence, Tiu, Ramon V., Hong, Wan-Jen, Tong, Bo, Qin, Qin, Dilley, Kimberley, Perl, Alexander E.

Volltext